SCHEMBL23259072

SCHEMBL23259072

COC(=O)c1ccc(-c2cc(C)cc(N3CCOCC3)n2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 5/20 0.54
PIK3CG P48736 3/20 0.54
MTOR P42345 1/20 0.54
AURKA O14965 2/20 0.52
PIK3CB P42338 3/20 0.51
ALDH1A1 P00352 5/20 0.49
HSD17B10 Q99714 3/20 0.49
HPGD P15428 2/20 0.49
ALOX15 P16050 2/20 0.49
MGLL Q99685 1/20 0.49
PIK3CD O00329 1/20 0.48
PIK3R2 O00459 1/20 0.48
BRD4 O60885 1/20 0.48
TSHR P16473 3/20 0.48
NPSR1 Q6W5P4 2/20 0.48
MAPT P10636 1/20 0.48
MAPK1 P28482 1/20 0.48
KDM4E B2RXH2 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
KMT2A Q03164 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24358696 0.88 PIK3CA (0.52) PIK3CAPIK3CGMTORAURKAPIK3CB
SCHEMBL23259440 0.86 MAPT (0.54) PIK3CAPIK3CGMTORPIK3CBALDH1A1
SCHEMBL23259071 0.78 MAPT (0.71) PIK3CAPIK3CGPIK3CBALDH1A1HSD17B10
SCHEMBL19367477 0.77 PIK3CA (0.60) PIK3CAPIK3CGMTORAURKAPIK3CB
SCHEMBL23259436 0.77 MAPT (0.55) PIK3CAPIK3CGMTORPIK3CBALDH1A1
SCHEMBL2260701 0.76 PIK3CA (0.51) PIK3CAPIK3CGMTORAURKAPIK3CB
SCHEMBL23269515 0.75 MAPT (0.50) PIK3CAPIK3CGMTORPIK3CBHSD17B10
SCHEMBL3714505 0.75 PIK3CA (0.48) PIK3CAPIK3CGMTORPIK3CBHSD17B10
SCHEMBL1063179 0.74 ALDH1A1 (0.67) PIK3CAPIK3CGMTORALDH1A1HSD17B10
SCHEMBL1579169 0.74 PIK3CA (0.58) PIK3CAPIK3CGMTORAURKAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220127266-A1 MALIC ENZYME INHIBITORS SUN PHARMA ADVANCED RESEARCH COMPANY LTD (IN) 2022-04-28 US disclosed
US-11225480-B2 Malic enzyme inhibitors SUN PHARMA ADVANCED RESEARCH COMPANY LTD (IN) 2022-01-18 US disclosed
US-20210115038-A1 MALIC ENZYME INHIBITORS SUN PHARMA ADVANCED RESEARCH COMPANY LTD (IN) 2021-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210115038-A1 MALIC ENZYME INHIBITORS ME1, ME2, ME3 PIK3CA 1318/4885PIK3CG 2455/4885MTOR 1289/4885
US-11225480-B2 Malic enzyme inhibitors ME1, RNASE1, ME2 PIK3CA 2039/4885PIK3CG 3833/4885MTOR 944/4885
US-20220127266-A1 MALIC ENZYME INHIBITORS ME1, ME2, ME3 PIK3CA 1318/4885PIK3CG 2455/4885MTOR 1289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.